The output for Basic Pharmaceutical Products and Preparations Manufacturing in Canada saw a significant growth trajectory from 2013 to 2023, starting at 10.5 billion CAD and climbing to 15.12 billion CAD in 2023. The industry experienced fluctuations with notable increases in 2014 (15.38%) and 2020 (8.6%), while 2017 saw a decline (-3.66%). The Compound Annual Growth Rate (CAGR) over the last five years was 2.87%, indicating steady growth.
From 2023 onwards, the forecast suggests continued growth, although at a slower pace, with a CAGR of 1.13% over the next five years, reaching 16.24 billion CAD by 2028. This represents a forecasted growth rate of 5.8% over five years.
Future trends to watch for include the impact of technological advancements in pharmaceutical manufacturing, regulatory changes, and potential market expansions due to increased demand for innovative therapies and vaccines. Additionally, global supply chain dynamics and emerging market influences could significantly impact production output.
